Related resources
Search for item elsewhere
University researcher(s)
Academic department(s)
Protein kinase A mediates activation of ATP-sensitive K+ currents by CGRP in gallbladder smooth muscle.
Zhang L, Bonev A, Mawe G, Nelson MT
American Journal of Physiology-Gastrointestinal and Liver Physiology. 1994;267( 3 Pt 1):G494-9.
Access to files
Full-text and supplementary files are not available from Manchester eScholar. Use our list of Related resources to find this item elsewhere. Alternatively, request a copy from the Library's Document supply service.
Abstract
The signal transduction mechanisms underlying the activation of ATP-sensitive potassium (KATP) current by calcitonin gene-related peptide (CGRP) in gallbladder smooth muscle were examined with intracellular microelectrode recording and whole cell patch-clamp techniques. In the intact gallbladder preparation, the adenylyl cyclase activator forskolin hyperpolarized the membrane potential and abolished spontaneous action potentials. This response was inhibited by the KATP channel blocker glibenclamide. CGRP (10 nM), forskolin (10 microM), the membrane-permeable adenosine 3',5'-cyclic monophosphate (cAMP) analogue adenosine 3',5'-cyclic monophosphothioate (Sp-cAMP[S]; 500 microM), and the catalytic subunit of protein kinase A (100 U/ml) activated glibenclamide-sensitive currents in enzymatically dissociated gallbladder smooth muscle cells. CGRP activation of potassium currents was prevented by dialysis of the cell cytoplasm with guanosine 5'-O-(2-thiodiphosphate) (5 mM) or a specific peptide inhibitor of protein kinase A (2.3 microM). Okadaic acid (5 microM), a phosphatase inhibitor, slowed the deactivation of the KATP current, following removal of CGRP. The results of this study indicate that CGRP hyperpolarizes gallbladder smooth muscle by elevation of cAMP and subsequent stimulation of protein kinase A.
Keyword(s)
Animals; Electrophysiology; Female; Guinea Pigs; Male; Okadaic Acid; analogs & derivatives: Guanosine Diphosphate; antagonists & inhibitors: Cyclic AMP-Dependent Protein Kinases; antagonists & inhibitors: Phosphoric Monoester Hydrolases; drug effects: Gallbladder; drug effects: Muscle, Smooth; drug effects: Potassium Channels; pharmacology: Adenosine Triphosphate; pharmacology: Calcitonin Gene-Related Peptide; pharmacology: Ethers, Cyclic; pharmacology: Forskolin; pharmacology: Glyburide; pharmacology: Thionucleotides